V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis

Trial Profile

V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Oct 2017

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Psychotic disorders
  • Focus Therapeutic Use
  • Acronyms V3
  • Most Recent Events

    • 11 Apr 2011 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 11 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Sep 2010 Additional lead trial centre and trial investigator (Honer W) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top